Cryoprecipitate use in the PROMMTT study.

Cryoprecipitate use in the PROMMTT study.

Item
http://www.wikidata.org/entity/Q37078363
The European guideline on management of major bleeding and coagulopathy following trauma: fourth editionFibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma.Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs.Cryoprecipitate therapy.The use of massive transfusion protocol for trauma and non-trauma patients in a civilian setting: what can be done better?State of the art: massive transfusion.Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review.Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage.Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy.Damage Control Resuscitation.
P2860

Cryoprecipitate use in the PROMMTT study.

Item
http://www.wikidata.org/entity/Q37078363
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cryoprecipitate use in the PROMMTT study.
@en
Cryoprecipitate use in the PROMMTT study.
@nl
type
label
Cryoprecipitate use in the PROMMTT study.
@en
Cryoprecipitate use in the PROMMTT study.
@nl
prefLabel
Cryoprecipitate use in the PROMMTT study.
@en
Cryoprecipitate use in the PROMMTT study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Cryoprecipitate use in the PROMMTT study.
@en
P2093
P2860
P304
P31
P356
10.1097/TA.0B013E31828FA3ED
P433
P478
P50
P577
P698
P932